Study S002247

Effect of Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03011008
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 20
Start: 2017-01
Primary completion: 2020-12
Lead sponsor: Second Xiangya Hospital of Central South University
Conditions: Type 1 Diabetes Mellitus; Autoimmune Diabetes
Interventions: DRUG:Liraglutide; DRUG:Insulin
Results posted: FALSE

Registered primary outcomes

Mean amplitude of glycemic excursions (MAGE) [1 year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0028263	Glucagon-like peptide-1: modulator of β-cell dysfunction and death. Rondas D, Diabetes, obesity & metabolism	2013	Narrative review	PMID 24003936 DOI	registry reference BACKGROUND:24003936